Pacer Advisors, Inc. Vertex Pharmaceuticals Inc Transaction History

Pacer Advisors, Inc.

  • $33.6 Billion
  • Q3 2025

A detailed history of Pacer Advisors, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 66,501 shares of VRTX stock, worth $27.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
66,501
Previous 39,958 66.43%
Holding current value
$27.1 Million
Previous $17.8 Million 46.41%
% of portfolio
0.08%
Previous 0.05%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025
BUY
$366.54 - $479.53 $9.73 Million - $12.7 Million
26,543 Added 66.43%
66,501 $26 Million
Q2 2025

Aug 12, 2025
BUY
$421.16 - $509.5 $3.9 Million - $4.72 Million
9,262 Added 30.17%
39,958 $17.8 Million
Q1 2025

May 06, 2025
SELL
$402.49 - $513.76 $3.26 Million - $4.16 Million
-8,104 Reduced 20.89%
30,696 $14.9 Million
Q4 2024

Jan 22, 2025
BUY
$396.64 - $516.74 $2.52 Million - $3.29 Million
6,359 Added 19.6%
38,800 $15.6 Million
Q3 2024

Nov 12, 2024
SELL
$460.0 - $505.78 $2.71 Million - $2.98 Million
-5,885 Reduced 15.36%
32,441 $15.1 Million
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $426,198 - $526,800
1,085 Added 2.91%
38,326 $18 Million
Q1 2024

May 10, 2024
SELL
$407.69 - $446.08 $1.64 Million - $1.79 Million
-4,011 Reduced 9.72%
37,241 $15.6 Million
Q4 2023

Jan 16, 2024
BUY
$343.0 - $410.68 $4.1 Million - $4.9 Million
11,940 Added 40.73%
41,252 $16.8 Million
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $1.19 Million - $1.27 Million
3,510 Added 13.6%
29,312 $10.2 Million
Q2 2023

Jul 12, 2023
SELL
$314.42 - $351.91 $3.69 Million - $4.13 Million
-11,750 Reduced 31.29%
25,802 $9.08 Million
Q1 2023

May 02, 2023
BUY
$283.23 - $323.1 $6.48 Million - $7.39 Million
22,887 Added 156.07%
37,552 $11.8 Million
Q4 2022

Feb 06, 2023
BUY
$285.76 - $321.48 $1.27 Million - $1.43 Million
4,439 Added 43.41%
14,665 $4.23 Million
Q3 2022

Oct 18, 2022
BUY
$273.83 - $305.53 $16,703 - $18,637
61 Added 0.6%
10,226 $2.96 Million
Q2 2022

Aug 12, 2022
SELL
$234.96 - $292.55 $681,618 - $848,687
-2,901 Reduced 22.2%
10,165 $2.86 Million
Q1 2022

Apr 05, 2022
SELL
$221.42 - $260.97 $1.86 Million - $2.19 Million
-8,387 Reduced 39.09%
13,066 $3.41 Million
Q4 2021

Feb 03, 2022
SELL
$177.01 - $223.45 $1.32 Million - $1.66 Million
-7,435 Reduced 25.74%
21,453 $4.71 Million
Q3 2021

Oct 15, 2021
BUY
$181.39 - $202.99 $352,803 - $394,815
1,945 Added 7.22%
28,888 $5.24 Million
Q2 2021

Jul 21, 2021
BUY
$187.49 - $221.1 $528,721 - $623,502
2,820 Added 11.69%
26,943 $5.43 Million
Q1 2021

Apr 05, 2021
SELL
$207.02 - $241.31 $438,468 - $511,094
-2,118 Reduced 8.07%
24,123 $5.18 Million
Q4 2020

Jan 20, 2021
SELL
$207.01 - $276.09 $2.54 Million - $3.38 Million
-12,246 Reduced 31.82%
26,241 $6.2 Million
Q3 2020

Oct 19, 2020
SELL
$255.65 - $303.1 $1.36 Million - $1.61 Million
-5,313 Reduced 12.13%
38,487 $10.5 Million
Q2 2020

Jul 29, 2020
BUY
$225.48 - $295.8 $5.17 Million - $6.78 Million
22,933 Added 109.9%
43,800 $12.7 Million
Q1 2020

Apr 23, 2020
BUY
$199.77 - $247.81 $122,059 - $151,411
611 Added 3.02%
20,867 $5.64 Million
Q4 2019

Feb 10, 2020
SELL
$166.71 - $223.91 $4.43 Million - $5.96 Million
-26,602 Reduced 56.77%
20,256 $4.44 Million
Q3 2019

Oct 10, 2019
BUY
$166.23 - $187.09 $939,199 - $1.06 Million
5,650 Added 13.71%
46,858 $7.94 Million
Q2 2019

Aug 12, 2019
BUY
$164.61 - $190.37 $667,987 - $772,521
4,058 Added 10.92%
41,208 $7.56 Million
Q1 2019

Apr 10, 2019
BUY
$163.73 - $194.7 $6.08 Million - $7.23 Million
37,150 New
37,150 $6.83 Million
Q4 2018

Feb 13, 2019
SELL
$151.91 - $192.21 $3.81 Million - $4.82 Million
-25,079 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $847,371 - $973,722
5,052 Added 25.23%
25,079 $4.83 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $525,466 - $612,875
3,606 Added 21.96%
20,027 $3.4 Million
Q1 2018

May 14, 2018
BUY
$151.6 - $177.13 $330,336 - $385,966
2,179 Added 15.3%
16,421 $2.68 Million
Q4 2017

Feb 14, 2018
BUY
$137.28 - $155.55 $810,501 - $918,367
5,904 Added 70.81%
14,242 $2.13 Million
Q3 2017

Nov 08, 2017
BUY
$148.13 - $162.24 $1.24 Million - $1.35 Million
8,338
8,338 $1.27 Million

Others Institutions Holding VRTX

# of Institutions
1,793
Shares Held
239M
Call Options Held
1.95M
Put Options Held
1.14M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email